Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

Recruiting now · Not applicable

Conditions studied: Lung Cancer - Non Small Cell, Lung Cancer (NSCLC)

In brief

Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.

Key facts

Study ID

NCT06786468

Run by

Mahidol University

People needed

104

Starts

2024-04-02

Expected to finish

2027-04-01

Last updated by the study team

2025-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age at least 18 years old
• Pathologically confirmed advanced non-small cell lung cancer
• Plan to receive systemic treatment for lung cancer within three weeks
• ECOG performance status 0-2 with estimated life expectancy > 24 weeks
• Having at least 4 scores according to Edmonton Symptom Assessment System (ESAS)
• Able to complete the questionnaires

You may not qualify if…

• Had received systemic treatment for advanced lung cancer before

Where it is running

• Siriraj Hospital — Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.